AR062304A1 - Composiciones con actividad elastizante mejorada - Google Patents
Composiciones con actividad elastizante mejoradaInfo
- Publication number
- AR062304A1 AR062304A1 ARP070103525A AR062304A1 AR 062304 A1 AR062304 A1 AR 062304A1 AR P070103525 A ARP070103525 A AR P070103525A AR 062304 A1 AR062304 A1 AR 062304A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- mixture
- risk
- component
- ester
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- -1 organic acid ester Chemical class 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 2
- JJVXHDTWVIPRBZ-VKHMYHEASA-N (2r)-2-[carboxy(methyl)amino]-3-sulfanylpropanoic acid Chemical compound OC(=O)N(C)[C@@H](CS)C(O)=O JJVXHDTWVIPRBZ-VKHMYHEASA-N 0.000 abstract 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract 1
- 229930182558 Sterol Natural products 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000035606 childbirth Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 229940016409 methylsulfonylmethane Drugs 0.000 abstract 1
- 210000002640 perineum Anatomy 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 235000003702 sterols Nutrition 0.000 abstract 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 abstract 1
- 229960003080 taurine Drugs 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 210000001215 vagina Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Uso de composiciones para mejorar la elasticidad de la vagina y del perineo durante el ultimo trimestre de embarazo, que incluyen la combinacion de un compuesto tiolado o mezcla de los mismos con un éster de ácido orgánico o mezcla de los mismos. Las composiciones mejoran las propiedades elásticas de los tejidos vaginales y/o perineales en términos tanto de mayor elasticidad como de una recuperacion elástica más rápida. Las composiciones pueden disminuir el riesgo de trauma en los tejidos perineales durante el parto, así como el riesgo de incontinencia rectal o urinaria como complicacion post-parto o a corto/mediano/largo plazo. Reivindicacion 3: Uso de acuerdo con la reivindicacion 1, caracterizado porque el componente a) se selecciona entre 1-metionina, 1-cisteína, 1-cistina, taurina, ácido 4-tiazolidina carboxílico, carboximetilcisteína y/o metilsulfonilmetano, o una sal de los mismos aceptable para uso fisiologico. Reivindicacion 7: Uso de acuerdo con la reivindicacion 1, caracterizado porque el componente b) es un éster de glicerol o un éster de esterol de origen animal o vegetal o una mezcla de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20060118649 EP1886676A1 (en) | 2006-08-09 | 2006-08-09 | Compositions with enhanced elasticizing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR062304A1 true AR062304A1 (es) | 2008-10-29 |
Family
ID=37575000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070103525 AR062304A1 (es) | 2006-08-09 | 2007-08-09 | Composiciones con actividad elastizante mejorada |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9125806B2 (es) |
| EP (2) | EP1886676A1 (es) |
| JP (2) | JP2010500309A (es) |
| KR (2) | KR20090050065A (es) |
| CN (1) | CN101500550B (es) |
| AR (1) | AR062304A1 (es) |
| AT (1) | ATE457723T1 (es) |
| BR (1) | BRPI0715182C1 (es) |
| CA (1) | CA2655472C (es) |
| CY (1) | CY1110032T1 (es) |
| DE (1) | DE602007004857D1 (es) |
| DK (1) | DK2049092T3 (es) |
| EA (1) | EA014971B1 (es) |
| ES (1) | ES2340335T3 (es) |
| HK (1) | HK1126956A1 (es) |
| HR (1) | HRP20100212T1 (es) |
| MX (1) | MX2009000869A (es) |
| NO (1) | NO343143B1 (es) |
| PL (1) | PL2049092T3 (es) |
| PT (1) | PT2049092E (es) |
| RS (1) | RS51282B (es) |
| SI (1) | SI2049092T1 (es) |
| WO (1) | WO2008017521A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3081212A1 (en) | 2015-04-16 | 2016-10-19 | Polichem SA | Carboxymethylcysteine for topical treatment of stretch marks |
| WO2017180174A1 (en) | 2016-04-15 | 2017-10-19 | Fairhaven Health, Llc | Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract |
| IT202100002285A1 (it) * | 2021-02-03 | 2022-08-03 | Farm Dott Ferretti Stefano | Nuova composizione |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1194912A (en) * | 1966-09-12 | 1970-06-17 | Mini Ind Chimice | Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin |
| US4296130A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
| GB9213472D0 (en) * | 1992-06-25 | 1992-08-12 | Unilever Plc | Cosmetic composition |
| CZ365996A3 (en) * | 1994-06-15 | 1997-10-15 | Procter & Gamble | Use of mercapto derivatives for preparing pharmaceutical preparation for making lighter of skin |
| JP3542665B2 (ja) * | 1995-07-07 | 2004-07-14 | 株式会社資生堂 | 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤 |
| FR2740340B1 (fr) * | 1995-10-30 | 1997-12-05 | Oreal | Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique |
| US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
| CH697081A5 (de) * | 2002-01-22 | 2008-04-30 | Andreas F Dr Schaub | Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten. |
| US6821524B2 (en) * | 2002-06-03 | 2004-11-23 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions |
| US20050266064A1 (en) * | 2004-05-29 | 2005-12-01 | Mccarthy Kathryn J | Cosmetic compositions and methods |
| US20060088496A1 (en) * | 2004-10-25 | 2006-04-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide |
| US7087560B2 (en) * | 2004-10-25 | 2006-08-08 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols |
| RU2375041C2 (ru) | 2004-10-25 | 2009-12-10 | Унилевер Н.В. | Композиции продуктов для персонального ухода с глицерином и солями дигидроксипропилчетвертичного аммония |
| DE102004054552A1 (de) * | 2004-11-11 | 2006-05-18 | Hcb Happy Child Birth Holding Ag | Neue Zusammensetzung zur Erleichterung der Humangeburt |
| US7351745B2 (en) * | 2004-12-22 | 2008-04-01 | Avon Products, Inc | Compositions and methods of their use for improving the condition and appearance of skin |
-
2006
- 2006-08-09 EP EP20060118649 patent/EP1886676A1/en not_active Withdrawn
-
2007
- 2007-04-18 RS RSP20100180 patent/RS51282B/sr unknown
- 2007-04-18 CN CN2007800296579A patent/CN101500550B/zh active Active
- 2007-04-18 AT AT07728255T patent/ATE457723T1/de active
- 2007-04-18 SI SI200730201T patent/SI2049092T1/sl unknown
- 2007-04-18 EP EP20070728255 patent/EP2049092B1/en active Active
- 2007-04-18 EA EA200900293A patent/EA014971B1/ru not_active IP Right Cessation
- 2007-04-18 WO PCT/EP2007/053793 patent/WO2008017521A2/en active Application Filing
- 2007-04-18 MX MX2009000869A patent/MX2009000869A/es active IP Right Grant
- 2007-04-18 PT PT07728255T patent/PT2049092E/pt unknown
- 2007-04-18 PL PL07728255T patent/PL2049092T3/pl unknown
- 2007-04-18 DE DE200760004857 patent/DE602007004857D1/de active Active
- 2007-04-18 KR KR20097004495A patent/KR20090050065A/ko active Search and Examination
- 2007-04-18 ES ES07728255T patent/ES2340335T3/es active Active
- 2007-04-18 JP JP2009523211A patent/JP2010500309A/ja active Pending
- 2007-04-18 BR BRPI0715182A patent/BRPI0715182C1/pt active IP Right Grant
- 2007-04-18 DK DK07728255T patent/DK2049092T3/da active
- 2007-04-18 US US12/310,032 patent/US9125806B2/en active Active
- 2007-04-18 KR KR1020147007704A patent/KR101521166B1/ko active IP Right Grant
- 2007-04-18 CA CA 2655472 patent/CA2655472C/en active Active
- 2007-08-09 AR ARP070103525 patent/AR062304A1/es not_active Application Discontinuation
-
2009
- 2009-03-06 NO NO20091011A patent/NO343143B1/no unknown
- 2009-05-19 HK HK09104533A patent/HK1126956A1/xx unknown
-
2010
- 2010-04-14 HR HR20100212T patent/HRP20100212T1/hr unknown
- 2010-05-14 CY CY101100418T patent/CY1110032T1/el unknown
-
2013
- 2013-07-08 JP JP2013142834A patent/JP5771649B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013007446A2 (pt) | afastador minimamente obstrutivo | |
| Cheng et al. | A brief review on anterior urethral strictures | |
| Hussein et al. | The use of penile skin graft versus penile skin flap in the repair of long bulbo-penile urethral stricture: a prospective randomized study | |
| AR061289A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
| DOP2007000041A (es) | Profarmacos mejorados de analogos de cc-1065 | |
| BR112012011075A2 (pt) | sistemas e métodos de liberação de material curável. | |
| HRP20161324T1 (hr) | Pripravci i postupci za povećavanje telomerazne aktivnosti | |
| AR062304A1 (es) | Composiciones con actividad elastizante mejorada | |
| BR112014015306A8 (pt) | dispositivo de inserção vaginal com segmentos perpendiculares | |
| SG10201906559QA (en) | Occlusion device for closing anatomical defects | |
| RU2011148301A (ru) | Способ синтеза производного эфира и глицирретиновой кислоты и соединение сложного эфира дезоксиглицирретиновой кислоты | |
| RU2011127304A (ru) | Способ реконструкции наружных женских половых органов при вирилизации наружных половых органов у девочек | |
| Ginther et al. | Natural rescue and resurgence of the equine corpus luteum | |
| Dabas et al. | Management of mummified fetus in a cow | |
| CN106344131B (zh) | 一种卵巢组织切片推送装置 | |
| CN107213453B (zh) | 一种流产药物 | |
| RU2009147874A (ru) | Способ эндохирургического лечения рецидивного сужения пиелоуретерального сегмента | |
| Zhang et al. | Long-term reproductive consequences of no-scalpel vasectomy in beagles | |
| Masuda | Editorial Comment to Longitudinal leak point pressure measurements in rats using a modified port à cath system. | |
| Khillare et al. | Acid and alkaline phosphatase enzyme activity in sperm storage tubules in Japanese quail | |
| Petros et al. | Use of Martius flaps in complex female urethral surgery and the tethered vagina syndrome | |
| Schnobrich | A review of the equine oviduct: pathology, evaluation, and current treatments | |
| CN201692135U (zh) | 一种节育环与止血海绵套管放置器 | |
| Patil et al. | Surgical Management of Recto-Vaginal Fistula with Atresia Ani in a Jersey Calf | |
| VanWye et al. | PSXIV-24 Inducing Luteolysis Before Atresia of the First Follicular Wave By Altering the Interval to Prostaglandin F2ɑ Administration After Long-Term Progestin Presynchronization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure | ||
| FC | Refusal |